272 related articles for article (PubMed ID: 17466655)
1. Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy.
Tashkin DP; Klein GL; Colman SS; Zayed H; Schonfeld WH
Am J Med; 2007 May; 120(5):435-41. PubMed ID: 17466655
[TBL] [Abstract][Full Text] [Related]
2. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
Brophy C; Kastelik J; Gardiner E; Greenstone M
Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
[TBL] [Abstract][Full Text] [Related]
3. The role of domiciliary nebulizers in managing patients with severe COPD.
Eiser N; Angus K; McHale S
Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.
Zuwallack R; De Salvo MC; Kaelin T; Bateman ED; Park CS; Abrahams R; Fakih F; Sachs P; Pudi K; Zhao Y; Wood CC;
Respir Med; 2010 Aug; 104(8):1179-88. PubMed ID: 20172704
[TBL] [Abstract][Full Text] [Related]
5. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
6. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
Balkissoon R; Make B
COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing.
Deerojanawong J; Manuyakorn W; Prapphal N; Harnruthakorn C; Sritippayawan S; Samransamruajkit R
Pediatr Pulmonol; 2005 May; 39(5):466-72. PubMed ID: 15786440
[TBL] [Abstract][Full Text] [Related]
8. Treatment of patients hospitalized for exacerbations of chronic obstructive pulmonary disease: comparison of an oral/metered-dose inhaler regimen and an intravenous/nebulizer regimen.
Shortall SP; Blum J; Oldenburg FA; Rodgerson L; Branscombe JM; Harrow EM
Respir Care; 2002 Feb; 47(2):154-8. PubMed ID: 11812271
[TBL] [Abstract][Full Text] [Related]
9. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
[TBL] [Abstract][Full Text] [Related]
10. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
11. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
12. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E
Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
[TBL] [Abstract][Full Text] [Related]
13. The effect of bronchodilators administered via aerochamber or a nebulizer on inspiratory lung function parameters.
Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
Respir Med; 2013 Sep; 107(9):1393-9. PubMed ID: 23768736
[TBL] [Abstract][Full Text] [Related]
14. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
15. Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response.
Duarte AG; Momii K; Bidani A
Respir Care; 2000 Jul; 45(7):817-23. PubMed ID: 10926377
[TBL] [Abstract][Full Text] [Related]
16. Does addition of inhaled steroid to combined bronchodilator therapy affect health status in patients with COPD?
Yildiz F; Basyigit I; Yildirim E; Boyaci H; Ilgazli A
Respirology; 2004 Aug; 9(3):352-5. PubMed ID: 15363007
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of nebulized albuterol/ipratropium bromide versus albuterol alone in the prehospital treatment of suspected reactive airways disease.
Davis DP; Wiesner C; Chan TC; Vilke GM
Prehosp Emerg Care; 2005; 9(4):386-90. PubMed ID: 16263670
[TBL] [Abstract][Full Text] [Related]
18. A prospective, comparative trial of standard and breath-actuated nebulizer: efficacy, safety, and satisfaction.
Arunthari V; Bruinsma RS; Lee AS; Johnson MM
Respir Care; 2012 Aug; 57(8):1242-7. PubMed ID: 22348319
[TBL] [Abstract][Full Text] [Related]
19. Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalers.
Chrischilles E; Gilden D; Kubisiak J; Rubenstein L; Shah H
Am J Manag Care; 2002 Oct; 8(10):902-11. PubMed ID: 12395958
[TBL] [Abstract][Full Text] [Related]
20. Inhalatory therapy training: a priority challenge for the physician.
Melani AS
Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
